APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Dec 01, 2023 | Option Exercise | $36.93 | 20,000 | 738,500 | 78,299 | Dec 05, 2023, 07:40 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Sep 06, 2023 | Sale | $43.01 | 1,756 | 75,526 | 68,299 | Sep 07, 2023, 04:08 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Feb 21, 2023 | Option Exercise | $58.50 | 715 | 41,828 | 69,643 | Feb 22, 2023, 06:49 AM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Feb 10, 2023 | Option Exercise | $51.21 | 678 | 34,720 | 60,472 | Feb 14, 2023, 04:44 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Jan 27, 2023 | Option Exercise | $52.77 | 542 | 28,601 | 61,150 | Jan 30, 2023, 05:03 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | Chief Research Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,015 | 104,881 | 61,692 | Jan 24, 2023, 05:22 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | May 27, 2022 | Sale | $43.00 | 10,000 | 430,000 | 40,358 | May 31, 2022, 04:30 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 05, 2022 | Option Exercise | $36.97 | 1,218 | 45,028 | 52,842 | Apr 06, 2022, 04:10 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 04, 2022 | Sale | $35.41 | 7,008 | 248,120 | 55,737 | Apr 05, 2022, 04:08 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 01, 2022 | Sale | $34.45 | 22,992 | 792,074 | 63,729 | Apr 04, 2022, 05:03 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 14, 2022 | Option Exercise | $26.73 | 720 | 19,246 | 52,233 | Feb 15, 2022, 04:58 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 08, 2022 | Option Exercise | $29.43 | 20,000 | 588,500 | 63,857 | Feb 10, 2022, 08:32 AM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Jan 31, 2022 | Sale | $38.47 | 1,233 | 47,434 | 53,857 | Feb 01, 2022, 05:58 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Jan 28, 2022 | Option Exercise | $38.59 | 642 | 24,775 | 55,090 | Feb 01, 2022, 05:58 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Jan 21, 2022 | Option Exercise | $26.73 | 3,021 | 80,751 | 29,681 | Jan 24, 2022, 05:26 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 10, 2021 | Option Exercise | $47.72 | 680 | 32,450 | 29,290 | Feb 11, 2021, 04:18 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Dec 08, 2020 | Option Exercise | $26.73 | 7,482 | 199,994 | 20,595 | Dec 09, 2020, 05:34 PM |
APLS | | Apellis Pharmaceuticals, Inc. | SCHEIBLER LUKAS | See Remarks | May 24, 2018 | Buy | $20.37 | 2,935 | 59,786 | 2,935 | May 29, 2018, 04:17 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Jul 17, 2017 | Sale | $6.50 | 1,250 | 8,125 | 11,108 | Jul 18, 2017, 02:14 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Jun 20, 2017 | Sale | $6.95 | 1,300 | 9,035 | 9,695 | Jun 20, 2017, 04:20 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | May 17, 2017 | Sale | $6.15 | 1,275 | 7,841 | 8,331 | May 18, 2017, 02:57 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Apr 17, 2017 | Sale | $6.48 | 1,320 | 8,554 | 6,943 | Apr 17, 2017, 04:50 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Mar 20, 2017 | Sale | $7.10 | 1,250 | 8,875 | 5,599 | Mar 20, 2017, 06:46 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Feb 17, 2017 | Sale | $8.10 | 1,450 | 11,745 | 4,186 | Feb 21, 2017, 07:11 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Jan 18, 2017 | Sale | $8.70 | 1,475 | 12,832 | 2,972 | Jan 20, 2017, 12:48 PM |
M?????? | | KUBOTA PHARMACEUTICAL HOLDINGS CO LTD | SCHEIBLER LUKAS | EVP of Research & Development | Dec 22, 2016 | Sale | $8.18 | 880 | 7,198 | 1,784 | Dec 27, 2016, 08:30 PM |
M?????? | | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Development | Nov 21, 2016 | Sale | $9.35 | 2,663 | 24,891 | 0 | Nov 21, 2016, 02:16 PM |
M?????? | | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Development | Nov 14, 2016 | Sale | $9.44 | 1,774 | 16,745 | 0 | Nov 15, 2016, 05:08 PM |
M?????? | | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Development | Oct 17, 2016 | Option Exercise | $11.48 | 890 | 10,220 | 1,774 | Oct 18, 2016, 03:39 PM |
M?????? | | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Development | Sep 20, 2016 | Sale | $9.53 | 2,663 | 25,382 | 0 | Sep 20, 2016, 12:57 PM |
M?????? | | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & Development | Aug 18, 2016 | Sale | $10.81 | 31,962 | 345,509 | 0 | Aug 18, 2016, 06:49 PM |